

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 8.84933163 |
| 2 | cytidine deamination (GO:0009972) | 7.67116917 |
| 3 | cytidine metabolic process (GO:0046087) | 7.67116917 |
| 4 | cytidine catabolic process (GO:0006216) | 7.67116917 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.79307120 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.48767755 |
| 7 | regulation of chronic inflammatory response (GO:0002676) | 5.20990829 |
| 8 | proteasome assembly (GO:0043248) | 4.75443505 |
| 9 | DNA double-strand break processing (GO:0000729) | 4.62189888 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.46233654 |
| 11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.35070340 |
| 12 | ATP synthesis coupled proton transport (GO:0015986) | 4.35070340 |
| 13 | pseudouridine synthesis (GO:0001522) | 4.32216457 |
| 14 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.31525698 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 4.29026481 |
| 16 | negative regulation by host of viral transcription (GO:0043922) | 4.11965266 |
| 17 | rRNA modification (GO:0000154) | 4.06450134 |
| 18 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.94688308 |
| 19 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.88029192 |
| 20 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.83014803 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.81304000 |
| 22 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.76449272 |
| 23 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.68632975 |
| 24 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.68632975 |
| 25 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.68632975 |
| 26 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.66468968 |
| 27 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.66468968 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.62774427 |
| 29 | rRNA methylation (GO:0031167) | 3.59901392 |
| 30 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.49811028 |
| 31 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.49811028 |
| 32 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.47090390 |
| 33 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.47090390 |
| 34 | isotype switching (GO:0045190) | 3.47090390 |
| 35 | positive regulation of defense response to virus by host (GO:0002230) | 3.46794919 |
| 36 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.45100759 |
| 37 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.41015555 |
| 38 | negative regulation of ligase activity (GO:0051352) | 3.38118503 |
| 39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.38118503 |
| 40 | eosinophil chemotaxis (GO:0048245) | 3.34751885 |
| 41 | positive regulation of lymphocyte migration (GO:2000403) | 3.32386833 |
| 42 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.32258947 |
| 43 | protein neddylation (GO:0045116) | 3.29451430 |
| 44 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.26498262 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.25750590 |
| 46 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.22469498 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.18928277 |
| 48 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.14813814 |
| 49 | positive regulation of ligase activity (GO:0051351) | 3.14808485 |
| 50 | positive regulation of T cell migration (GO:2000406) | 3.14449945 |
| 51 | electron transport chain (GO:0022900) | 3.12165101 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.09055401 |
| 53 | GTP biosynthetic process (GO:0006183) | 3.07951090 |
| 54 | respiratory electron transport chain (GO:0022904) | 3.07482739 |
| 55 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.07156275 |
| 56 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.07156275 |
| 57 | sequestering of actin monomers (GO:0042989) | 3.04309002 |
| 58 | chaperone-mediated protein transport (GO:0072321) | 3.01982624 |
| 59 | eosinophil migration (GO:0072677) | 3.01329062 |
| 60 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.99296420 |
| 61 | regulation of T cell chemotaxis (GO:0010819) | 2.94754991 |
| 62 | positive regulation of T cell chemotaxis (GO:0010820) | 2.94754991 |
| 63 | modulation by host of symbiont transcription (GO:0052472) | 2.94610902 |
| 64 | modulation by host of viral transcription (GO:0043921) | 2.94610902 |
| 65 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.94213984 |
| 66 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.93814708 |
| 67 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.93681297 |
| 68 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.87849444 |
| 69 | inner mitochondrial membrane organization (GO:0007007) | 2.87450743 |
| 70 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.83234059 |
| 71 | platelet dense granule organization (GO:0060155) | 2.83037185 |
| 72 | peptidyl-histidine modification (GO:0018202) | 2.82787053 |
| 73 | positive regulation of cell cycle arrest (GO:0071158) | 2.79887272 |
| 74 | cullin deneddylation (GO:0010388) | 2.79744319 |
| 75 | regulation of cellular amine metabolic process (GO:0033238) | 2.78748826 |
| 76 | regulation of endothelial cell differentiation (GO:0045601) | 2.78410712 |
| 77 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.78378914 |
| 78 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.77426100 |
| 79 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.76992304 |
| 80 | positive regulation of T cell apoptotic process (GO:0070234) | 2.76588263 |
| 81 | negative regulation of viral genome replication (GO:0045071) | 2.76009056 |
| 82 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.74494656 |
| 83 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.74141035 |
| 84 | DNA demethylation (GO:0080111) | 2.73336873 |
| 85 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.72753540 |
| 86 | termination of RNA polymerase III transcription (GO:0006386) | 2.70590631 |
| 87 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.70590631 |
| 88 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.70027624 |
| 89 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.69907945 |
| 90 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.67947846 |
| 91 | negative regulation of telomere maintenance (GO:0032205) | 2.67889610 |
| 92 | protein deneddylation (GO:0000338) | 2.66998404 |
| 93 | maturation of 5.8S rRNA (GO:0000460) | 2.65603375 |
| 94 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.64544936 |
| 95 | vitamin biosynthetic process (GO:0009110) | 2.60869560 |
| 96 | regulation of ligase activity (GO:0051340) | 2.60742074 |
| 97 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.59258851 |
| 98 | nucleoside diphosphate catabolic process (GO:0009134) | 2.58424617 |
| 99 | protein complex biogenesis (GO:0070271) | 2.58387692 |
| 100 | negative regulation of T cell apoptotic process (GO:0070233) | 2.56007389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.42965740 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.82287555 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.26783738 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.93062277 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.71468962 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.70096790 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.35015415 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.78435041 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.61591266 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59617637 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.59400298 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.51693015 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46205805 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40786310 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31508537 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29438667 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.24283136 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.14445900 |
| 19 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.03591317 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99639918 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.97580208 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91672398 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87626482 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.85746450 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81209093 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71360702 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.70884374 |
| 28 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68781583 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.65536164 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59677480 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57714051 |
| 32 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.55631648 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.51024377 |
| 34 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49455332 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48152969 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48148490 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44463396 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43794249 |
| 39 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.42119098 |
| 40 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.41758646 |
| 41 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39290397 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36009029 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.34490917 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26431948 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23415599 |
| 46 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.21924271 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.21924271 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16657154 |
| 49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14270966 |
| 50 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14270966 |
| 51 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13473575 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12967766 |
| 53 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11242067 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10951191 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09631286 |
| 56 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09517408 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09398057 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09224994 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09093459 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08680141 |
| 61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08003052 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06896543 |
| 63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06314362 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06202661 |
| 65 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05280663 |
| 66 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.04768170 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04725737 |
| 68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02652291 |
| 69 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.02584065 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00913964 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99802505 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98914376 |
| 73 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98367560 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97243920 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97107257 |
| 76 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.95969089 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95813595 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95199085 |
| 79 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95122477 |
| 80 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94490302 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93934242 |
| 82 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93651237 |
| 83 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.92764695 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 0.92630425 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91417441 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90697325 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.87244109 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.86404926 |
| 89 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86024093 |
| 90 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.85976682 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.85941074 |
| 92 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85766672 |
| 93 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.85231484 |
| 94 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85135201 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84137061 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83856407 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83022932 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82344199 |
| 99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81840009 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.81568432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.61655144 |
| 2 | MP0005671_abnormal_response_to | 4.34984759 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.54373860 |
| 4 | MP0002102_abnormal_ear_morphology | 2.64622906 |
| 5 | MP0000685_abnormal_immune_system | 2.56947027 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.54646064 |
| 7 | MP0003195_calcinosis | 2.50001153 |
| 8 | MP0009785_altered_susceptibility_to | 2.49936974 |
| 9 | MP0000015_abnormal_ear_pigmentation | 2.47603488 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.42934779 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.39541347 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.35211638 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.29208909 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.29152255 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.25363752 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.15142677 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.09049804 |
| 18 | MP0001800_abnormal_humoral_immune | 2.03044197 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.98467854 |
| 20 | MP0002006_tumorigenesis | 1.92869431 |
| 21 | MP0003786_premature_aging | 1.88132197 |
| 22 | MP0005387_immune_system_phenotype | 1.87835641 |
| 23 | MP0001790_abnormal_immune_system | 1.87835641 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.82672239 |
| 25 | MP0006072_abnormal_retinal_apoptosis | 1.73102719 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.71555002 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.70743510 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 1.70656933 |
| 29 | MP0005408_hypopigmentation | 1.65642828 |
| 30 | MP0002277_abnormal_respiratory_mucosa | 1.61218435 |
| 31 | MP0003186_abnormal_redox_activity | 1.55601567 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.54199553 |
| 33 | MP0002723_abnormal_immune_serum | 1.49382338 |
| 34 | MP0009379_abnormal_foot_pigmentation | 1.46360926 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.44852785 |
| 36 | MP0008872_abnormal_physiological_respon | 1.42548511 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.41739093 |
| 38 | MP0003436_decreased_susceptibility_to | 1.39405668 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.38191603 |
| 40 | MP0001919_abnormal_reproductive_system | 1.35818223 |
| 41 | MP0009764_decreased_sensitivity_to | 1.35807305 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.33966942 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.32479888 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.32156589 |
| 45 | MP0001819_abnormal_immune_cell | 1.31849473 |
| 46 | MP0008058_abnormal_DNA_repair | 1.30939050 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.26913090 |
| 48 | MP0002095_abnormal_skin_pigmentation | 1.25623762 |
| 49 | MP0005025_abnormal_response_to | 1.24791887 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.23585754 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.22104840 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.20730149 |
| 53 | MP0003718_maternal_effect | 1.20415056 |
| 54 | MP0003646_muscle_fatigue | 1.19027514 |
| 55 | MP0002398_abnormal_bone_marrow | 1.16776273 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.14715590 |
| 57 | MP0005389_reproductive_system_phenotype | 1.12638150 |
| 58 | MP0009697_abnormal_copulation | 1.08686853 |
| 59 | MP0003011_delayed_dark_adaptation | 1.08302683 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.06531329 |
| 61 | MP0005085_abnormal_gallbladder_physiolo | 1.04191181 |
| 62 | MP0002163_abnormal_gland_morphology | 1.02575958 |
| 63 | MP0000716_abnormal_immune_system | 1.02575052 |
| 64 | MP0008995_early_reproductive_senescence | 1.01738538 |
| 65 | MP0003880_abnormal_central_pattern | 1.01540446 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.01070558 |
| 67 | MP0003252_abnormal_bile_duct | 0.99110866 |
| 68 | MP0002405_respiratory_system_inflammati | 0.97378636 |
| 69 | MP0009745_abnormal_behavioral_response | 0.96197372 |
| 70 | MP0002938_white_spotting | 0.95221530 |
| 71 | MP0001293_anophthalmia | 0.92847697 |
| 72 | MP0004142_abnormal_muscle_tone | 0.91715830 |
| 73 | MP0006082_CNS_inflammation | 0.91570961 |
| 74 | MP0000371_diluted_coat_color | 0.91533393 |
| 75 | MP0010094_abnormal_chromosome_stability | 0.88002878 |
| 76 | MP0002429_abnormal_blood_cell | 0.85517247 |
| 77 | MP0002736_abnormal_nociception_after | 0.85365853 |
| 78 | MP0001905_abnormal_dopamine_level | 0.85157645 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.85123107 |
| 80 | MP0002272_abnormal_nervous_system | 0.84448682 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.82546183 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.82089959 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.77913591 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.77730743 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.76443360 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.76398870 |
| 87 | MP0005253_abnormal_eye_physiology | 0.75914939 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.75895656 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.75455819 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.73352372 |
| 91 | MP0002160_abnormal_reproductive_system | 0.69576510 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.68937956 |
| 93 | MP0005365_abnormal_bile_salt | 0.68749371 |
| 94 | MP0005332_abnormal_amino_acid | 0.68216438 |
| 95 | MP0002419_abnormal_innate_immunity | 0.68018870 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.67411144 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 0.65872371 |
| 98 | MP0002722_abnormal_immune_system | 0.65113515 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.63191421 |
| 100 | MP0004742_abnormal_vestibular_system | 0.62292444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.66349044 |
| 2 | Increased IgM level (HP:0003496) | 4.33024860 |
| 3 | IgG deficiency (HP:0004315) | 4.05808007 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 3.78100749 |
| 5 | T lymphocytopenia (HP:0005403) | 3.31727502 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.21077344 |
| 7 | Fair hair (HP:0002286) | 3.20570389 |
| 8 | Pancreatic fibrosis (HP:0100732) | 3.14040937 |
| 9 | Pancreatic cysts (HP:0001737) | 3.12862738 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.10929386 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.08668356 |
| 12 | Abnormality of T cells (HP:0002843) | 3.08412518 |
| 13 | Colon cancer (HP:0003003) | 3.07299468 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 3.01602968 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98531766 |
| 16 | Increased CSF lactate (HP:0002490) | 2.95882776 |
| 17 | Aplastic anemia (HP:0001915) | 2.91218365 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.90783497 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.90783497 |
| 20 | Hypoproteinemia (HP:0003075) | 2.88600565 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86185524 |
| 22 | Nephronophthisis (HP:0000090) | 2.84775238 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 2.83146950 |
| 24 | Albinism (HP:0001022) | 2.82527081 |
| 25 | Hepatocellular necrosis (HP:0001404) | 2.80301887 |
| 26 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.77878747 |
| 27 | Abnormality of alanine metabolism (HP:0010916) | 2.77878747 |
| 28 | Hyperalaninemia (HP:0003348) | 2.77878747 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.72726181 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.72526687 |
| 31 | Increased serum lactate (HP:0002151) | 2.68837770 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 2.65107712 |
| 33 | Chronic diarrhea (HP:0002028) | 2.65099847 |
| 34 | Encephalitis (HP:0002383) | 2.62288408 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.61648254 |
| 36 | Tubular atrophy (HP:0000092) | 2.52877973 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.52267518 |
| 38 | True hermaphroditism (HP:0010459) | 2.51220823 |
| 39 | IgA deficiency (HP:0002720) | 2.50568443 |
| 40 | Parakeratosis (HP:0001036) | 2.50468508 |
| 41 | Hypoplasia of the pons (HP:0012110) | 2.50377902 |
| 42 | Pendular nystagmus (HP:0012043) | 2.46822664 |
| 43 | Hepatic necrosis (HP:0002605) | 2.45752375 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.45489813 |
| 45 | Generalized hypopigmentation of hair (HP:0011358) | 2.45072587 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44549155 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.42964901 |
| 48 | Oral leukoplakia (HP:0002745) | 2.42591189 |
| 49 | Abnormality of the renal medulla (HP:0100957) | 2.40449386 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.40088530 |
| 51 | Pancytopenia (HP:0001876) | 2.38959448 |
| 52 | Molar tooth sign on MRI (HP:0002419) | 2.38567626 |
| 53 | Abnormality of midbrain morphology (HP:0002418) | 2.38567626 |
| 54 | Exertional dyspnea (HP:0002875) | 2.36509050 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.36181557 |
| 56 | Acute encephalopathy (HP:0006846) | 2.35549485 |
| 57 | Recurrent viral infections (HP:0004429) | 2.30954800 |
| 58 | Cerebral edema (HP:0002181) | 2.28373831 |
| 59 | Abnormality of the pons (HP:0007361) | 2.26596057 |
| 60 | Renal Fanconi syndrome (HP:0001994) | 2.26504968 |
| 61 | Methylmalonic aciduria (HP:0012120) | 2.24209555 |
| 62 | Decreased central vision (HP:0007663) | 2.15576500 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.13649099 |
| 64 | Amniotic constriction ring (HP:0009775) | 2.12531154 |
| 65 | Abnormality of placental membranes (HP:0011409) | 2.12531154 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.10398610 |
| 67 | Thyroid-stimulating hormone excess (HP:0002925) | 2.09230512 |
| 68 | Abnormality of vitamin B metabolism (HP:0004340) | 2.08799738 |
| 69 | Supernumerary spleens (HP:0009799) | 2.08373410 |
| 70 | Abnormality of the renal cortex (HP:0011035) | 2.06731126 |
| 71 | Abnormality of macular pigmentation (HP:0008002) | 2.06720477 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.01670630 |
| 73 | Abnormality of the labia minora (HP:0012880) | 2.01013176 |
| 74 | Lactic acidosis (HP:0003128) | 1.98608242 |
| 75 | Homocystinuria (HP:0002156) | 1.98054901 |
| 76 | Abnormality of homocysteine metabolism (HP:0010919) | 1.98054901 |
| 77 | Neutropenia (HP:0001875) | 1.97435855 |
| 78 | Thyroiditis (HP:0100646) | 1.96566012 |
| 79 | Optic disc pallor (HP:0000543) | 1.96037587 |
| 80 | Polydipsia (HP:0001959) | 1.95790003 |
| 81 | Abnormal drinking behavior (HP:0030082) | 1.95790003 |
| 82 | Abnormality of renal resorption (HP:0011038) | 1.95501220 |
| 83 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.94507529 |
| 84 | Respiratory failure (HP:0002878) | 1.91307991 |
| 85 | Sclerocornea (HP:0000647) | 1.91262802 |
| 86 | Cerebral hemorrhage (HP:0001342) | 1.90887199 |
| 87 | Severe combined immunodeficiency (HP:0004430) | 1.88695356 |
| 88 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88390254 |
| 89 | Lethargy (HP:0001254) | 1.87872508 |
| 90 | Myositis (HP:0100614) | 1.85236577 |
| 91 | Abnormality of B cell number (HP:0010975) | 1.84358550 |
| 92 | Leukodystrophy (HP:0002415) | 1.81576860 |
| 93 | Lymphoma (HP:0002665) | 1.81419600 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 1.80282937 |
| 95 | Cutaneous melanoma (HP:0012056) | 1.76523485 |
| 96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.75948773 |
| 97 | Agammaglobulinemia (HP:0004432) | 1.73955440 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.72886518 |
| 99 | Melanoma (HP:0002861) | 1.72143103 |
| 100 | Hypomagnesemia (HP:0002917) | 1.70973434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.83197287 |
| 2 | VRK2 | 3.62280920 |
| 3 | TAF1 | 2.86404131 |
| 4 | MAP3K12 | 2.85943562 |
| 5 | WNK4 | 2.80183876 |
| 6 | MAP4K2 | 2.66639117 |
| 7 | NUAK1 | 2.58021930 |
| 8 | ADRBK2 | 2.57634977 |
| 9 | BUB1 | 2.46208899 |
| 10 | TAOK3 | 2.45903456 |
| 11 | OXSR1 | 2.40512224 |
| 12 | STK39 | 2.34263332 |
| 13 | DAPK2 | 2.20885293 |
| 14 | KDR | 2.11463259 |
| 15 | EIF2AK3 | 2.00713209 |
| 16 | PIK3CG | 1.98965695 |
| 17 | TESK2 | 1.97373490 |
| 18 | GRK1 | 1.95916147 |
| 19 | VRK1 | 1.90092706 |
| 20 | ZAK | 1.79902650 |
| 21 | BMPR2 | 1.69565791 |
| 22 | TLK1 | 1.55082081 |
| 23 | TXK | 1.52119974 |
| 24 | IKBKB | 1.45166633 |
| 25 | CCNB1 | 1.38767815 |
| 26 | WNK3 | 1.38057979 |
| 27 | FRK | 1.34225539 |
| 28 | MYLK | 1.30791718 |
| 29 | PLK3 | 1.17991346 |
| 30 | EIF2AK1 | 1.17471351 |
| 31 | BCKDK | 1.11039394 |
| 32 | PLK2 | 1.10896585 |
| 33 | TSSK6 | 1.06509939 |
| 34 | BMPR1B | 1.01936164 |
| 35 | ITK | 0.99603485 |
| 36 | DAPK1 | 0.99599454 |
| 37 | ILK | 0.98400386 |
| 38 | PLK4 | 0.96336721 |
| 39 | TEC | 0.91501084 |
| 40 | GRK5 | 0.89442207 |
| 41 | NEK1 | 0.85098597 |
| 42 | CDC7 | 0.80342687 |
| 43 | NME1 | 0.76661925 |
| 44 | MAP2K6 | 0.75966177 |
| 45 | INSRR | 0.74492689 |
| 46 | DAPK3 | 0.72780907 |
| 47 | SIK3 | 0.72147977 |
| 48 | PTK2B | 0.68087327 |
| 49 | PDK2 | 0.65744194 |
| 50 | AURKB | 0.65421582 |
| 51 | TRIM28 | 0.63564680 |
| 52 | ALK | 0.62775210 |
| 53 | IKBKE | 0.62712831 |
| 54 | EIF2AK2 | 0.61398923 |
| 55 | CLK1 | 0.60902247 |
| 56 | PAK3 | 0.60099477 |
| 57 | GRK6 | 0.59890792 |
| 58 | TESK1 | 0.59464013 |
| 59 | MAPKAPK5 | 0.59243234 |
| 60 | CDK19 | 0.58681663 |
| 61 | STK16 | 0.58671773 |
| 62 | ATR | 0.58364757 |
| 63 | SYK | 0.58097905 |
| 64 | DYRK2 | 0.57267611 |
| 65 | SRPK1 | 0.57249300 |
| 66 | STK4 | 0.57129045 |
| 67 | RIPK4 | 0.56121251 |
| 68 | TIE1 | 0.55410353 |
| 69 | LCK | 0.55265117 |
| 70 | GRK7 | 0.53394019 |
| 71 | LIMK1 | 0.52646129 |
| 72 | CAMK1 | 0.52088452 |
| 73 | PRKCQ | 0.51452560 |
| 74 | FES | 0.50760987 |
| 75 | OBSCN | 0.49695963 |
| 76 | PLK1 | 0.46727164 |
| 77 | BRD4 | 0.45916957 |
| 78 | CAMK2A | 0.44902164 |
| 79 | SMG1 | 0.44343957 |
| 80 | PRKCE | 0.43811209 |
| 81 | CSNK1G3 | 0.43638154 |
| 82 | CHUK | 0.41506606 |
| 83 | PRKCI | 0.40650866 |
| 84 | FGFR1 | 0.39266225 |
| 85 | CDK7 | 0.38793275 |
| 86 | ADRBK1 | 0.38323394 |
| 87 | MKNK2 | 0.37977060 |
| 88 | WEE1 | 0.36888244 |
| 89 | AURKA | 0.36646865 |
| 90 | CAMKK2 | 0.36124280 |
| 91 | CAMK4 | 0.35947023 |
| 92 | RPS6KA5 | 0.35416588 |
| 93 | MAP4K1 | 0.34058141 |
| 94 | RPS6KA4 | 0.33992799 |
| 95 | CAMK2D | 0.33085220 |
| 96 | CSNK1G1 | 0.32576415 |
| 97 | BCR | 0.32334502 |
| 98 | CSNK2A1 | 0.31545874 |
| 99 | PRKACA | 0.30467601 |
| 100 | PAK4 | 0.30410852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.52113854 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19124122 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.14156550 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.92296651 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.89257755 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.53933239 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.52358541 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.42625096 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38911749 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.24445565 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.20853131 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20804547 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.19391335 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.12751122 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06841640 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.01278817 |
| 17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.90492593 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.89302566 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.87665498 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87005174 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84521306 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79056519 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67970758 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.60110955 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.43002777 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.33442248 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28928031 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.27342553 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.24620887 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.16494158 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14187589 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.12992507 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11522122 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10354649 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05527446 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.05128558 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04282923 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 1.03690788 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02774176 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02209955 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99564687 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97459904 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96328033 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.96102141 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95636858 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94531404 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87009934 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86360263 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 0.85174225 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.83408655 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83199721 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81128012 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79690098 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72057904 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70890658 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67502211 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62604221 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61901412 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.60569399 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59682454 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56003135 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55415364 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54973288 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53082943 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52544739 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49176919 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48940849 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44035659 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.43690676 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.42751370 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.41143443 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39321204 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38922994 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35888796 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35208280 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34003392 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33846409 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33394514 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33067106 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32455875 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31946624 |
| 82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31554343 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30908778 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30866895 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30434143 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29780722 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29389290 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27822502 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27762576 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.27458021 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24081509 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23638292 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23047171 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22694483 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22497733 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22196485 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.22110975 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.21996501 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.21612396 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21609770 |

